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Abstract: Methods for analyzing the terminal sequences of proteins have been refined over the
previous decade; however, few studies have evaluated the quality of the data that have been produced
from those methodologies. While performing global N-terminal labelling on bacteria, we observed
that the labelling was not complete and investigated whether this was a common occurrence. We
assessed the completeness of labelling in a selection of existing, publicly available N-terminomics
datasets and empirically determined that amine-based labelling chemistry does not achieve complete
labelling and potentially has issues with labelling amine groups at sequence-specific residues. This
finding led us to conduct a thorough review of the historical literature that showed that this is not
an unexpected finding, with numerous publications reporting incomplete labelling. These findings
have implications for the quantitation of N-terminal peptides and the biological interpretations of
these data.
Keywords: terminomics; mass spectrometry; amine labelling
1. Introduction
Quantitative proteomics has become a widely used tool in the biological sciences, inferring
biological significance from the changes in protein abundance between varying treatments or
conditions. Protein quantification studies normally use an organism’s reference genome to identify
and quantify products of an organism’s open reading frames (ORFs). This approach, while
useful for quantitation of predicted protein products, does not take into consideration the various
post-translational modifications (PTMs) that may occur on a protein, or the presence of biologically
distinct proteoforms arising from a single ORF. Identifying specific proteoforms and quantifying
their abundance levels is necessary for a complete assessment of proteomic variation and its
biological significance.
The production of mature proteoforms is an intricate process, as outlined in Figure 1 [1–3].
ORFs by definition are inferred by bioinformatic prediction from genome sequencing projects, often
without direct proteomic evidence to confirm their accuracy [4–6]. Variations resulting from chemical
modifications to the nascent protein (PTMs), such as acetylation and phosphorylation, as well as
primary structural modifications by proteolytic cleavage, introduces a level of proteome complexity
that is often overlooked when using reference genomes to detect the presence of a particular ORF
using mass spectrometry [7–9]. Considering proteolytic cleavage in particular, the most prevalent
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PTM in biological systems, mature proteoforms that are products of proteolysis are often incorrectly
represented in protein databases as a non-mature, direct translation of the ORF. Our extensive work
examining Mycoplasma spp., considered the ‘simplest’ self-replicating organism yet discovered, has
shown that proteolytic cleavage is a critical process in the generation of mature proteoforms from
large ORFs, producing a larger proteome than bioinformatically predicted for these genome-reduced
bacteria [10]. In addition, proteolysis creates proteoforms that have different functionality to the parent
proteoform, further extending proteome complexity [10–22]. This increase in proteome diversity
through proteolysis also occurs in eukaryotes, and this presents a need to identify and characterize
proteoforms produced through proteolysis in order to understand proteoform diversity and its
effect on biological systems, rather than quantifying the abundance of aggregated ORF products.
However, despite a range of methodologies being available to achieve this, the methods are often
not able to definitively identify the diversity of proteoforms on a proteome-wide scale or in a high
throughput manner.
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Figure 1. Schematic for the various methods for the production of proteoforms. Final protein
products may be modified during transcription or during translation at the ribosome. Alternatively,
nascent polypeptide chains may be modified after translation with a myriad of post-translational
modifications. Once translated, the protein sequence can often require further modifications to perform
a specialized function, generating proteoforms that vary from the original expressed protein [2,3,23].
Post-translational modifications such as phosphorylation, a reversible chemical addition to the protein,
or proteolysis, a permanent hydrolysis event removing amino acid(s) from the polypeptide chain, cause
important functional changes in proteins [24,25].
The original method for analyzing intact proteoforms and protein sequences was Edman
degradation, which allows direct and unambiguous sequencing of the N-terminal amino acids of
intact, purified proteins [3,26–28]. Nevertheless, Edman degradation is a time-consuming process,
sequencing one amino acid residue per hour, and is limited by the efficiency of the chemical reagents to
hydrolyze the peptide bonds of each subsequent residue [26–29]. The ideal solution for characterizing
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intact proteoforms is direct sequencing in a complex proteome sample using intact mass spectrometry
(MS), with high-resolution accurate mass measurements and MS/MS fragmentation. Intact protein
MS/MS (or Top Down MS) analysis can determine the N-and C-terminal sequences of a proteoform by
matching of spectral data to the predicted ORF, as well as detecting the presence and location of PTMs,
where the difference in proteoform mass corresponds exactly to the PTM mass [30–32]. However,
higher throughput and increased proteome depth (at the expense of proteoform identification) can
be achieved by analyzing peptides from enzymatically digested proteins using traditional shotgun
Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS), with routine identification of
~11,000 ORF products [33–35] compared to <1500 proteoforms identified by Top Down MS [36].
In order to characterize the N- or C-terminus of the mature proteoforms, the terminal peptide must be
unambiguously identified to avoid conjecture, which can be challenging if the true terminal peptide
is not ‘MS friendly’ and thus undetectable due to poor ionization potential or unsuitable length
after digestion. A solution for these issues which has been implemented by several groups [37–40]
is the application of protein-level labelling and enrichment of terminal peptide sequences after
proteolytic digestion, known collectively as “terminomics”. While these methods are able to reduce
the aforementioned ambiguity, they are not free of problems.
Currently, the most popular terminomics techniques target the identification of the N-terminus
of proteoforms by enriching and sequencing N-terminal peptides by MS, which are then mapped to
ORFs in silico [41–43]. Enrichment aims to address the biggest obstacle encountered in terminomics
and proteomics, which is the complexity of the sample being analyzed, as a sample containing tens
of thousands of proteoforms will produce an exponentially larger number of peptides of varying
abundance to be analyzed following enzymatic cleavage [44,45]. This is exemplified by the fact that
the 15,721 human proteins or ORFs that have been detected and catalogued in ProteomicsDB, arguably
the most comprehensive proteome resource available, are described by 455,289 unique peptides, with
peptide evidence for 7977 N-termini and 6778 C-termini [46]. The competition of peptides for detection
in MS can be addressed through the selected isolation of only N-terminal peptides via N-terminomics
enrichment strategies, enabling the complexity of the sample to be reduced and minimizing signal
competition during MS, thereby improving N-terminal sequence identification [41].
Bottom-up MS proteome analysis assigns peptide sequences to ORFs using bioinformatics;
however, information about the original intact proteoform is often lost [3,47,48]. For example,
proteoforms differing by a single amino substitution cannot be distinguished if the peptide containing
the substitution is not detected. In the case of proteolytic processing, the main problem of bottom-up
methodologies is the previously mentioned unambiguous assignment of the N-termini of mature
proteoforms. This is best illustrated by considering a digest of Bovine Serum Albumin (BSA). In a
majority of cases when analyzing peptides, the MS1 scan range is usually set between 350–1500 m/z
to optimize the transmission of ions through the quadrupole for high sensitivity and to avoid low
mass, but high signal ‘background’ ions being detected. The lower mass of 350 m/z is also set to avoid
selecting small peptides of less than 3–5 amino acids (AAs) for fragmentation and MS/MS, as these
are scored against by search algorithms as they are more likely to be matched randomly. In the case of
BSA, the N-terminal site is well known (UniProt P02796) and the mature proteoform starts at Aspartic
Acid (D, position 19) after removal of the signal and pro-peptide. After digestion with trypsin, the
peptide created at the N-terminal of the proteoform is DTHK, which would have a monoisotopic mass
of 500.24 m/z, while the 2+ ion would be 250.62 m/z, which is below the normally utilized scan range.
The first detectable and assigned peptide of the sequence in our experience is FKDLGEEHFK (AAs
34–44) which includes a missed tryptic cleavage site. If this was an uncharacterized protein with no
knowledge of the mature proteoform, such shotgun LC/MS/MS data would erroneously assign the
N-terminal amino acid.
The difficulty of identifying proteoforms using shotgun LC/MS/MS is further compounded
when trying to characterize proteoforms generated by the cleavage of large precursor proteins,
exemplified by the adhesin families of Mycoplasma hyopneumoniae. This organism overcomes a small
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genome of less than 700 ORFs by performing extensive proteolytic cleavage of expressed proteins
into mature proteoforms, such as the cleavage of mhp683 [12]. This ORF is processed into three main
proteoforms of 45, 48, and 50 kDa, a fact not able to be determined by shotgun LC/MS/MS but
revealed through prior fractionation by proteoform mass using one dimensional PolyAcrylamide Gel
Electrophoresis (SDS-PAGE), where peptides mapping to the entire ORF are found at approximately
50 kDa. The individual proteoforms are resolvable by Two Dimensional PAGE (Isoelectric focusing
followed by SDS-PAGE), and LC/MS/MS analysis of peptides from the 48 kDa proteoform (designated
P48) revealed the true N-terminus due to the presence of pyroglutamate, formed by the cyclisation
of the side chain of glutamate or glutamine with its free α-amine. This ‘labelling’ of the N-terminus,
where the mass of the AA has been altered by the formation of pyroglutamate (which can be removed
by enzymatic treatment with pyroglutaminase), led us to explore the literature for other methods of
labelling to distinguish the true N-termini of mature proteoforms. Most strategies for N-terminomics,
such as COmbined FRActional DIagonal Chromatography (COFRADIC) and Terminal Amine Isotopic
Labeling of Substrates (TAILS), implement the use of a chemical label [42,49–52], where sample
complexity is then simplified by either positive or negative enrichment of labelled N-terminal peptides
for analysis by LC/MS/MS [3].
The most popular approach to N-terminal labelling of proteoforms involves exploiting the
apparent chemical reactivity of the free primary amine group on the N-terminus and lysine side
chain [3,43,53]. As is the case for numerous chemical reactions, including Edman degradation,
labelling procedures are restrained by the efficiency of the chemical reaction to modify the targeted
amine groups and attach the chemical label [40,43,54]. In our laboratory, there has been evidence to
suggest incomplete dimethyl labelling of proteoforms isolated from bacteria, especially the lysine-rich
Mycoplasmas, with cases of lysine being identified as the N-terminal amino acid but possessing only
one dimethyl tag instead of the expected two (Figure 2). This observation was made because our
peptide search parameters have dimethylation set as a variable modification, which is in contrast
to the consensus in the literature to use fixed modifications. This led us to suspect that incomplete
labelling was more widespread than being reported. Several groups have explored the efficiency of
the dimethylation procedure (listed in Table 1), but each quote different sets of conditions that are
“optimal” for protein sample labelling. Additionally, none of these groups have systematically reported
the effect of protein concentration or the level of proteome complexity that is compatible with the
dimethyl–amine chemistry or other labelling techniques [55–57].
Examination of data from experiments using reductive dimethylation in our laboratory and
comparing it to other reports prompted us to question whether the dimethylation labelling was
complete with all primary amines labelled when performed on different organisms with higher
lysine content. This also raised the question of whether the data in current N-terminomics literature is
underreporting the completeness of labelling, potentially leading to inaccurate quantitation. To address
this, we have performed a meta-analysis on a selection of publically available, quantitative datasets
which implemented a dimethyl labelling protocol without peptide depletion.




Figure 2. Dimethylation reaction implemented in the UTS Proteomics Core Facility with examples of
incomplete labelling. (A) Theoretical reductive dimethylation reaction shown, which will attach two
methyl groups to every prime amine in a protein sample (N-terminus and lysine residues). However,
preliminary experimental results of the dimethylation process indicate that the current method is
not modifying all primary amine groups in complex samples. (B) Unpublished data of incomplete
labelling occurring in a model protein sample (bovine serum albumin). The N-terminal sequence that
was obtained indicated that the protein amino acid sequence began with aspartic acid (Letter symbol,
D), which was confirmed with bovine serum albumin data from UniProt (accession number: P02769).
Identical peptide sequences containing lysine residues have been sequenced by mass spectrometry;
however, the first peptide, indicated in the red rectangle, has been identified with only the lysine
dimethylated. (C) The second sequence from the same mass spectrometry experiment has a dimethyl
label on both the N-terminal amine (the aspartic acid residue) and lysine residue.
2. Materials and Methods
2.1. Data Selection
Raw MS/MS data files were obtained from the online proteomics data repository, PRoteomics
IDEntifications (PRIDE) Archive (Table 2). All analyzed datasets implemented dimethyl labelling
protocols involving no enrichment strategy and labelling at the peptide level (after sample digestion);
thus, all detected peptides should be dimethylated if all primary amines had reacted. Our meta-analysis
omits datasets with ambiguously named data files, no raw MS/MS data, or labelling strategies which
utilized peptide depletion protocols (e.g., N-TAILS). The reason for omitting datasets generated with
depletion strategies is that the negative selection of amine-containing peptides, which should be the
internal peptides generated by proteolytic digestion after dimethylation, will remove any incompletely
labelled peptides, preventing their analysis by LC/MS/MS. We were therefore forced to omit studies
that used dimethylation at the protein level, the technique that is of most value for the determination
of the N-termini of mature proteoforms, because the relevant data was not being captured in the
experiment. The datasets used for re-analysis were selected as randomly as possible to cover as many
types of organisms as possible.
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2.2. Data Search and Analysis
Data files obtained from PRIDE were subsequently searched using the PEAKS Studio software
package (v8.5) with the relevant organism sequence database, while the specific instrument parameters
were as per those reported in each study, but with the relevant modifications set to variable rather
than fixed (see Supplemental Table S1 for full specifications). The PEAKS search results were filtered
to remove sample contaminants and then sorted to identify spectra that match to the same sequence
(duplicate sequences). All significant (p ≤ 0.05) duplicate sequences were interrogated for frequency of
complete, partial, or total lack of dimethyl labelling by assessing the proportion of duplicate sequences
detected with a label at the N-terminus and at any lysine residues.
3. Results
In this meta-analysis, we sought to examine whether dimethylation was present on all
primary amines in peptides in published data utilizing a non-depleted dimethyl labelling protocol.
It is important to point out that many of the studies examined performed database searching
with dimethylation as a fixed modification, thus assuming that all primary amines present were
dimethylated. If dimethylation of all available reactive amines does not occur, as we suspect that
it does not, the search parameters applied in these studies will either not assign all of the acquired
spectra, resulting in a false negative, or assign a spectrum to the incorrect sequence, resulting in a false
positive. Our analysis, presented in Table 2, found that between 6–18% of duplicate sequences detected
in each dataset have amine groups that are not dimethylated, which was not reported by the authors.
These peptide matches are therefore false negatives, a value that is normally not able to be calculated.
As these are peptide-based, shotgun LC/MS/MS experiments, the need to calculate false discovery
rates (FDR) is a mandatory requirement of many reviewers and journals, and it is generally accepted
that the FDR be below 1% [58–60]. Our analysis assigned FDRs to each dataset of ≤3%. In the case of
these studies, the false negative rate is far greater than the false positive rate reported in the individual
studies, and this is of serious concern when quantitation is considered as it will lead to false values.
The meta-analysis also revealed that a portion of the acquired MS/MS spectra are unassigned
in the original publications, indicating that potentially important protein/peptide information is
being overlooked in the final quantification. The number of peptides displaying a dimethyl label
varied between each sample, with only 81–94% of all peptides demonstrating a dimethylated -amine
and, in the case of lysine terminating peptides, a dimethylated -amine. It is possible that this is an
underestimation. Prior published evidence [61,62] indicates that the ability of a primary amine to be
dimethyl-labelled may be relative to the characteristics of the protein sample (reviewed in greater
detail by Feeney and Blankenhorn [63]). This data may suggest that there are variations in labelling
between organisms; however, this view is not supported by the meta-analysis conducted here. Jentoft
and Dearborn [61] provided evidence that extreme concentrations of formaldehyde and NaBH3CN
will not result in complete modification of primary amines in proteins, but concluded that reductive
methylation may be implemented quantitatively. In contrast, Gidley and Sanders [64] found that the
yields are never quantitative, and there always appears to be unchanged starting material present at
the completion of the reaction, which is in contrast to the current understanding and implementation
of the technique as reported in the literature.
One study that does report a completeness of labelling is Rowland et al. [65], where the labelling
efficiency of lysine residues in the chloroplast proteome of A. thaliana was reported to be ≥99%
for detected peptides. This may be attributed to protein preparation and reaction conditions, or
the inherent characteristics of proteoforms present in the investigated proteome [61,62,66]. While
these data [65] are available on the online proteomics data repository PRIDE (dataset identifier
PXD002476 and 10.6019/PXD002476), it was difficult for us to determine with complete certainty
which files corresponded to the dimethyl efficiency testing, so the data was unable to be included in
our meta-analysis. This is not an uncommon issue, and there needs to be a dedicated effort made to
properly label raw data files so that the results can be independently validated.
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Inconsistency in labelling of raw data files available from online data repositories was only one
issue encountered that hindered data acquisition. A large number of studies performing reductive
dimethylation experiments failed to upload raw data files onto online data repositories, which restricted
the number of datasets available for analysis. Results from our meta-analysis indicate that in the
datasets analyzed, dimethylation was not complete; however, more data is required to understand
the more widespread implications of this observed inefficiency. As such, we acknowledge and echo
the recommendations of Lange et al. [67] and strongly encourage others to upload raw data files with
clear, understandable filenames onto online data repositories.
In our meta-analysis, we were unable to include datasets from studies utilizing TAILS or
negative selection of peptides because incompletely labelled peptides would be captured by the
polyaldehyde polymers used to capture all molecules with free primary amines. These studies
implement dimethylation at the protein level, which is of most relevance to our need to identify mature
proteoforms. In our experience, protein level labelling is not complete, and we have no reason to
suspect that protein level labelling is complete in TAILS-based analysis or other systems. Studies
implementing chemical labelling strategies for quantitative analyses need to be aware that labelling
efficiency can be variable and incomplete with important implications for data analysis, so we suggest
that the extent of this should be empirically analyzed by searching the data with demethylation as a
variable modification to determine the completeness of labelling. Once determined, the researcher can
decide whether to proceed with the quantitative experiment and report the completeness of amine
labelling. In SILAC experiments, it is generally accepted that the heavy amino acid be incorporated
into >95% of the peptides detected before the quantitative experiment is performed, and this should
be the case for chemical labelling strategies.
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Table 1. Published reaction conditions of reductive methylation protocols.
Reference (Year) Reaction Conditions Reactant Concentrations Significant Observations
Friedman et al. [66] (1974)




~11 mM aldehyde (various)
Modification of lysine resides ranged from 40–90% using different aldehyde reagents,
between protein molecules and different amino acid residues
Jentoft et al. [61] (1979)





concentration of lysyl residues in sample
80–90% dimethyl conversion of lysine residues with a 6 fold excess of formaldehyde
Lower concentrations of NaBH3CN (5 mM to 20 mM) yielded in the highest
modifications of lysyl residues
Maximal rates of labelling observed at pH 8
Hsu et al. [68] (2005) Sodium acetate bufferpH 5–85 min
~22 mM NaBH3CN
~52 mM formaldehyde Observation of immonium ion signal with dimethyl labelling
Krusemark et al. [69] (2008)
2 h, room temperature
300 mM triethanolamine and 6 mM
Guanidine–HCL buffer pH 7.5 20% MeOH
1 mg/mL protein
30 mM Pyridine-BH3 (reducing agent)
20 mM formaldehyde
4 model proteins containing various abundance of amine groups, dimethyl
labelled to completeness
NaBH3CN and NaBH4 found to produce side reactions resulting in reduced
purity of products
Boersema et al. [70] (2009)
1 h, room temperature
100 mM Triethylamonium bicarbonate buffer
pH 5–8.5
~22 mM NaBH3CN
~52 mM formaldehyde (protocol paper)
Kleifeld et al. [43] (2011) 4 h—overnight incubation at 37
◦C
100 mM HEPES pH 7.0
20 mM NaBH3CN
40 mM formaldehyde (protocol paper)
Jhan et al. [71] (2017) 30 s–2h, room temperature100 mM sodium acetate pH 5–6
1.4–85 mM NaBH3CN
156 mM formaldehyde
Accessibility of primary amines on the protein greatly affects dimethylation efficiency
At 30 s 80% of amines were dimethylated







































1.7 6658 5454 81.92 1161 17.44 43 0.65 1204 18.08
PRD000055
(115)
0.6 5395 5062 93.83 315 5.84 18 0.33 333 6.17
PXD005920
(126)
1.5 3269 2847 87.09 404 12.36 18 0.55 422 12.91
PXD003298
(127)
1.6 3531 2893 81.93 584 16.54 54 1.53 638 18.07
PXD004654
(128)
3.0 6293 5498 87.37 715 11.36 80 1.27 795 12.63
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4. Discussion
Over a number of years, our laboratory has been interested in the characterization of proteolytic
processing that occurs in prokaryotes to generate proteome diversity from a relatively small genome.
Through the use of protein-centric techniques, especially 2D-PAGE, we showed the extent of processing
in the model bacteria Mycoplasma hyopneumoniae, but we were unable to definitively identify the point
of cleavage because we could not be sure that a peptide closer to the N-terminal was not being
detected because it was not ‘MS-friendly’. In an attempt to resolve this, we turned to reductive
dimethylation as a method of labelling the N-terminal amine of mature proteoforms, but we found that
the ‘completeness’ of the labelling was less than that reported in the wider literature. In an attempt to
understand why this was the case here, we have performed a meta-analysis on a random selection of
N-terminomics datasets with surprising results. The significant issue is that the search parameters used
to identify dimethylated peptides assume that all amines are modified, which is a flawed assumption
as very few chemical reactions proceed to absolute completion and some potential reactants are always
left over. During reanalysis, we found a significant number of unlabeled peptides in the datasets, which
are false negatives in the original published analysis. This brings into question some of the conclusions
of any publications seeking to use reductive dimethylation in a quantitative manner. It is clear that
more work needs to be performed to further characterize the reductive dimethylation chemistry and
workflows. During our analysis, we had difficulty identifying datasets which met the selection criteria
for the meta-analysis, due to poor annotation of datasets in PRIDE or the use of enrichment tools which
disguise the presence of unlabeled peptides. It is clear that we need to investigate other chemistries,
such as succinimide-based chemistries utilized in Isobaric Tags for Relative and Absolute Quantitation
(iTRAQ) or Tandem Mass Tags (TMT) protocols, which may provide a more complete labelling or may
suffer similar shortfalls as the dimethylation reaction.
Supplementary Materials: The following are available online at http://www.mdpi.com/2227-7382/7/2/11/s1,
Table S1: Parameters used to re-analyze the datasets listed in Table 1.
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